Pharmacy Practice Faculty/Staff Directory

Michael P. Rivey

M.S., BCPS, FASHP

Contact

Education

Board Certified Pharmacotherapy Specialist, 1991 - present

M.S. Pharmacy, University of Iowa (1982)

B.S. Pharmacy, University of Iowa (1974)

Courses Taught

Therapeutics II and III

Integrated Studies IV & V

APPE:  Inpatient and Hospital Practice

pieces in various other courses

 

Teaching Experience

PHAR 452: Therapeutics II

PHAR 552/3: Therapeutics III (Course Coordinator)

PHAR 472/571/574: Integrated Studies

Preceptor: Inpatient Clinical Clerkship (plus various specialty clerkships), Community Medical Center

Research Interests

Thromboembolic Disease

Adult Internal Medicine

Neurological Disease

Asthma

Projects

various topics surrounding asthma care

various topics surrounding pharmacotherapy of multiple sclerosis

various topics surrounding anticoagualtion

Field of Study

clinical pharmacy

Selected Publications

last 5 years

Tietje TM, Davis AB, Rivey MP.  Comparison of two methods of local anesthetic-based injection as part of a multimodal approach to pain management after total knee arthoplasty.  J Pharm Practice 2014. Accepted for publication June 2014.

Aikens GB, Osmundson JR, Rivey MP.  New oral pharmacotherapeutic agents for venous thromboprophylaxis after total hip arthroplasty.  World J Orthop 2014; 5:188-203.  Invited review.  Published online July 2014.  http://dx.doi.org/10.5312/wjo.v5.i3.188

Rivey MP, Allington DR.  Gastrointestinal Infections with Enterotoxigenic Bacterium.  Cases 146 &147. ASHP’s PharmPrep 5th Edition, Ginsburg DB, editor, American Society of Health-
System Pharmacists, Bethesda, MD. 2013.   Accepted for publication.

Allington DR, Rivey MP.  Multiple sclerosis (MS) in a primary care setting: Employing strategies for improved patient outcomes.  Invited continuing education (CE) program for ScientiaCME.  Program included Powerpoint slide set with audio presentation, CE post-test questions, and recommendation for future program.  Nov 2013.

Tietje TM, Allington DR, Rivey MP.  Alemtuzumab: A place in therapy for multiple sclerosis.  Int J Clin Med 2013;4:459-71.  Published online October 2013 http://dx.doi.org/10.423/ijcm.2013.410082

Allington DR, Davis A, Sutton J, Rivey MP.  Multiple Sclerosis: Fundamental concepts and clinical perspectives.  Book chapter 22 for Advances in Viral Research II.  iConcept Press LTD.  ISBN: 978-1477555-04-0. Sept 2013.  

Aikens GB, Rivey MP, Hansen CJ.  Primary venous thromboembolism prophylaxis in ambulatory cancer patients.  Ann Pharmacother 2013;47:198-209.  Published online February 5, 2013.
doi 10.1345/aph.1R335

Nwankwo E, Allington DR, Rivey MP.  Emerging oral immunomodulating agents- focus on teriflunomide for the treatment of multiple sclerosis.  Degenerative Neurological and Neuromuscular Disease 2012; 2:15-28.

Summerday NM, Brown SJ, Allington D, Rivey MP.  Vitamin D and Multiple Sclerosis: Review of a possible association.  J Pharm Practice 2012:25:75-84.  e-publication in October 2011.
doi: 10.1177/0897190011421839

Rivey MP.  Anticoagulation Therapy: A Point-of-Care Guide (book review).  Ann Pharmacother 2011; 45:1034-5.  Published online July 5, 2011. DOI 10.1345/aph.1Q188

Rivey MP.  Pharmacotherapy Principles & Practice, 2nd edition (book review).  Ann Pharmacother 2010; 44: 2042.  Published online Nov 23, 2010.  DOI10.1345/aph.1P485

Barten LJ, Allington DR, Procacci KA, Rivey MP.  New approaches in the management of multiple sclerosis.  Drug Design, Development and Therapy 2010:4:1-23.

Rivey MP, Allington DR.  Gastrointestinal Infections with Enterotoxigenic Bacterium.  Cases 146 & 147. ASHP’s PharmPrep 4th Edition, Ginsburg DB, editor,  American Society of Health
System Pharmacists, Bethesda, MD. 2010.   Published as online cases.

Barten LJ, Allington DR, Procacci KA, Rivey MP.  Natalizumab update:  a story of benefit and risk.  Drug Discovery Today: Therapeutic Strategies 2009.  DOI 10.1016/j.ddstr.2009.10.002  

Publications

see 'Selected Publications' for past 5 years only

Tietje TM, Davis AB, Rivey MP.  Comparison of two methods of local anesthetic-based injection as part of a multimodal approach to pain management after total knee arthoplasty.  J Pharm Practice 2014. Accepted for publication June 2014.

Aikens GB, Osmundson JR, Rivey MP.  New oral pharmacotherapeutic agents for venous thromboprophylaxis after total hip arthroplasty.  World J Orthop 2014; 5:188-203.  Invited review.  Published online July 2014.  http://dx.doi.org/10.5312/wjo.v5.i3.188

Rivey MP, Allington DR.  Gastrointestinal Infections with Enterotoxigenic Bacterium.  Cases 146 & 147. ASHP’s PharmPrep 5th Edition, Ginsburg DB, editor, American Society of Health-
System Pharmacists, Bethesda, MD. 2013.   Accepted for publication.

Allington DR, Rivey MP.  Multiple sclerosis (MS) in a primary care setting: Employing strategies for improved patient outcomes.  Invited continuing education (CE) program for ScientiaCME.  Program included Powerpoint slide set with audio presentation, CE post-test questions, and recommendation for future program.  Nov 2013.

Tietje TM, Allington DR, Rivey MP.  Alemtuzumab: A place in therapy for multiple sclerosis. Int J Clin  Med 2013;4:459-71.  Published online October 2013 http://dx.doi.org/10.4236/ijcm.2013.410082

Allington DR, Davis A, Sutton J, Rivey MP.  Multiple Sclerosis: Fundamental concepts and clinical perspectives.  Book chapter 22 for Advances in Viral Research II.  iConcept Press LTD. ISBN: 978-1477555-04-0. Sept 2013.  

Aikens GB, Rivey MP, Hansen CJ.  Primary venous thromboembolism prophylaxis in ambulatory cancer patients.  Ann Pharmacother 2013;47:198-209.  Published online February 5, 2013.
doi 10.1345/aph.1R335

Nwankwo E, Allington DR, Rivey MP.  Emerging oral immunomodulating agents- focus on teriflunomide for the treatment of multiple sclerosis.  Degenerative Neurological and Neuromuscular Disease 2012; 2:15-28.

Summerday NM, Brown SJ, Allington D, Rivey MP.  Vitamin D and Multiple Sclerosis: Review of a possible association.  J Pharm Practice 2012:25:75-84.  e-publication in October 2011.
doi: 10.1177/0897190011421839

Rivey MP.  Anticoagulation Therapy: A Point-of-Care Guide (book review).  Ann Pharmacother 2011; 45:1034-5.  Published online July 5, 2011. DOI 10.1345/aph.1Q188

Rivey MP.  Pharmacotherapy Principles & Practice, 2nd edition (book review).  Ann Pharmacother 2010; 44: 2042.  Published online Nov 23, 2010.  DOI10.1345/aph.1P485

Barten LJ, Allington DR, Procacci KA, Rivey MP.  New approaches in the management of multiple sclerosis.  Drug Design, Development and Therapy 2010:4:1-23.

Rivey MP, Allington DR.  Gastrointestinal Infections with Enterotoxigenic Bacterium.  Cases 146 & 147. ASHP’s PharmPrep 4th Edition, Ginsburg DB, editor,  American Society of Health
System Pharmacists, Bethesda, MD. 2010.   Published as online cases.

Barten LJ, Allington DR, Procacci KA, Rivey MP.  Natalizumab update:  a story of benefit and risk.  Drug Discovery Today: Therapeutic Strategies 2009.  DOI 10.1016/j.ddstr.2009.10.002  

Korenke AR, Rivey MP, Allington DR.  Sustained-release fampridine for symptomatic treatment of multiple sclerosis.  Ann Pharmacother 2008;42:1458-65

Rivey MP, Allington DR.  Gastrointestinal Infections.  Cases 146 & 147.  ASHP’s PharmPrep 3rd Edition, Ginsburg DB, editor,  American Society of Health System Pharmacists, Bethesda, MD. 2007.  

Allington DR, Rivey MP.  Gastrointestinal infections.  Case 147.  ASHP’s PharmPrep 3rd Edition, Ginsburg DB, editor,  American Society of Health System Pharmacists, Bethesda, MD. 2007. 

Patrick BN, Rivey MP, Allington DR.  Acute renal failure associated with vancomycin- and tobramycin-laden cement in total hip arthroplasty.  Ann Pharmacother 2006;40:2037-42.

Colucci VJ and Rivey MP.  Potential contribution of long-term rofecoxib in a patient with cardiogenic syncope and ischemic stroke.  J Pharm Technol 2006;22:174-8.
 
Keeley KA, Rivey MP, Allington DR.  Natalizumab in the treatment of multiple sclerosis and Crohn’s disease.  Ann Pharmacother 2005;39:1833-43.

Rivey MP, Allington DR, Mathis JB.  Evaluation of a risk assessment approach to venous thromboembolism (VTE) prophylaxis in medically ill patients.  Pharmacotherapy
2005;25:1502 (abstract).

Brophy DF, Dougherty JA, Garrelts JC, Parish RC, Rivey MP, Stumpf JL, Taylor CT, Mathis AS. Venous thromboembolism prevention in acutely ill nonsurgical patients.  Ann Pharmacother
2005;39:1318-24.

Keeley KA, Mathis JB, Rivey MP.  Medication Reconciliation in Hospitalized Patients.  The New Montana Pharmacist 2005; summer issue: pp 6-7.  (nonrefereed)

Rivey MP, Allington DR.  Gastrointestinal infections with enterotoxigenic bacterium. Case 146.  pp 96-98.  ASHP’s PharmPrep 2nd Edition,  Ginsburg DB, editor,  American Society of Health System Pharmacists, Bethesda, MD. 2004  

Rivey MP, Allington DR.  Gastrointestinal infections with enterotoxigenic bacterium. Case 147.  CD medium.  ASHP’s PharmPrep 2nd Edition,  Ginsburg DB, editor,  American Society of Health System Pharmacists, Bethesda, MD. 2004  

Rivey MP, Beall HD, Woolley D, Brand P, Ganser A, James W.  Investigation of intraarticular bupivacaine in major orthopedic surgery for postoperative pain control.  Pharmacotherapy 2001;21:366-7 (abstract).

Allington DR, Rivey MP.  Quinupristin/dalforpristin: A therapeutic review.  Clin Ther 2001;23:24-44.

Struckman DR, Rivey MP.  Combined therapy with an angiotensin II receptor blocker and an angiotensin-converting enzyme inhibitor in heart failure.  Ann Pharmacother 2001;35:242-8.

McHugh M, Allington DR, Rivey MP.  Combination aspirin and dipyridamole & secondary stroke prevetion.  Montana Pharmacist 2000;24(No.3):6-7.  (not refereed)

Carter JT, Allington DR, Rivey MP.  Medical rehabilitation clerkship experience for Pharm.D. students.  Am J Pharm Educ 2000;64:96S (abstract).

Colucci VJ, Rivey MP.  Tolterodine-warfarin drug interaction.  Ann Pharmacother 1999;33:1173-6.

Messer KG, Rivey MP.  Feasibility study for pharmacist-directed asthma management in a pediatric practice.  Pharmacotherapy 1999;19:521 (abstract).

Rivey MP, Allington DR, Henry Dunham AL.  Necrotizing fasciitis associated with nonsteroidal antiinflammatory drug use.  J Pharm Technol 1998;14:58-62.

Rivey MP.  Pharmacist-managed drug therapy protocols at Community Medical Center.  MSHP Newsletter 1997;6(No.3):3-5.  (not refereed)

Stone JD, Rivey MP, Allington DR.  Nitroprusside treatment of erythromelalgia in an adolescent female.  Ann Pharmacother 1997;31:590-2.

Rivey MP, Wood RD, Allington DR, Stratton TP, Erickson CC, Stenson TA.  Pharmacy-managed protocol for warfarin use in orthopedic surgery patients. Am J Health-Syst Pharm 1995;52:1310-6.

Rivey MP, Allington DR, Stone JD, Serfoss ML.  Alteration of carbamazepine pharmacokinetics in patients with traumatic brain injury.  Brain Injury 1995;9:41-7.

Allington DR, Rivey MP.  Multiple Sclerosis: An overview.  American Pharmacy 1994, accepted for publication, but never published.

Rivey MP, Wood RD, Allington DR, Erickson CC.  Evaluation of CoumadinR Protocol in Orthopedic Surgery Patients.  Pharmacotherapy 1993;13:272 (abstract).  Report in HospFormulary Oct 1993.

Rivey MP and Peterson JP.  Pharmacy-managed, weight-based heparin protocol in a small hospital.  Am J Hosp Pharm 1993;50:279-84.  Report in Clinical Digest Series

Rivey MP, Allington DR, Stone JD.  Evidence for alteration of carbamazepine pharmacokinetics during chronic therapy in patients with closed head injury.  Pharmacotherapy 1992;12:505 (abstract).  Report in CA/CTF.

Rivey MP, North GL, Harper DA, Cochran TG, Simmerman J.  Evolution of a neonatal gentamicin dosing protocol in a small community hospital.  J Perinatol 1992;12:346-53.

Rivey MP.  Hepatitis: A viral alphabet.  Montana Pharmacist     1992; 15(3):15-7 (not refereed)

Rivey MP and Stone JD.  Carbamazepine hypersensitivity reaction.  Brain Injury 1991;5:57-62.

Rivey MP and Peterson JP.  Intradermal hepatitis B vaccination.  DICP Ann Pharmacother 1991; 25:628-34.

Rivey MP.  The School of Pharmacy self-study: What was it, and what did it say?  Montana Pharmacist 1991;14:17-9.  (not refereed)

Rivey MP.  Psychotropic medication and falls in the elderly.  Montana Pharmacist 1991;14:24-6.  (not refereed)

Rivey MP, Morin LJ, Haakenson P.  Attitudes of first-year pharmacy students and preceptors to a "mini-externship" in hospital and community pharmacy practice.  Am J Pharm Educ     1990;54:146-9.

Rivey MP.  Warfarin: New developments for an old drug.  Montana Pharmacist 1990;13(1);11-4.  (not refereed)

Freeman D, Cochran G, Rivey M.  Search for alterations in red blood cell enzymes in Alzheimer's Disease (abstract).  Proc Mont Acad Sci 1989;49:165.

Rivey MP, Taylor JW, and Mullenix TA.  TMP/SMX in renally-impaired patients with P. carinii pneumonia.  Drug Intell Clin Pharm 1989;23:687-9.

Rivey MP.  The use of technicians in pharmacy: A present perspective.  Montana Pharmacist 1988;11:7-8,14.  (not refereed)

Berg MJ, Ebert BE, Rivey NP, and Schottelius DD.  Utilization of Km for phenytoin dosage after folate addition to patient regimen.  Ther Drug Monitor 1987;9:304-305.

Rivey MP, Docktor WJ, and Winship MJ.  Aminoglycoside monitoring in the neonate.  Drug Intell Clin Pharm 1985;19:908-909.

Taylor JW, Murphy MJ, and Rivey MP.  Clinical and electrophysiological evaluation of peripheral nerve function in chronic phenytoin therapy.  Epilepsia 1985;26:416-420.

Rivey MP, Alexander MR, and Taylor JW.  Dipyridamole: A critical evaluation.  Drug Intell Clin Pharm 1984;18:869-880.

Taylor JW, Alexander B, Kathol RG, Alexander MR, Ebert B, and Rivey MP.  Pharmacokinetic analysis of phenytoin-disulfiram interaction (abstract).  Drug Intell Clin Pharm 1984;18:499.

Rivey MP, Schottelius DD, and Berg MJ.  Phenytoin-folic acid: A review.  Drug Intell Clin Pharm 1984;18:292-301.

Berg MJ, Rivey MP, Vern BA, Fischer LJ, and Schottelius DD.  Phenytoin and folic acid: Individualized drug interaction.  Ther Drug Monitor 1983;5:389-394.

Berg, MF, Fischer LJ, Rivey MP, Vern VA, and Schottelius DD.  Phenytoin and folic acid interaction: A preliminary report.  Ther Drug Monitor 1983;5:389-394.

Rivey MP.  The Effect of Folic Acid Supplementation on Phenytoin Pharmacokinetics in Seizure Patients.  MS Pharm Thesis, University of Iowa, December 1982.

Affiliations

Community Medical Center:  Pharmacy consultant & residency program manager

Professional Experience

Practice Site

Name: Community Medical Center
Address: 2827 Fort Missoula Road, Missoula, MT 59804
Phone: (406) 728-4100 (x7605)

International Experience

Visiting Research Professor, Queen's University Belfast, No. Ireland.  Academic sabbatical Jul-Dec, 2014

Honors / Awards

Fellow, American Society of Health-Systems Pharmacists